Episode 593: Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?

Best Science Medicine Podcast - BS without the BS

In episode 593, Mike and James invite Samantha Moe back to talk about a newer agent for osteoporosis. So, if you want to know all the evidence for romosozumab, tune in and all will be revealed about the benefits and harms.

Show notes
1) Tools for Practice
Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?

2) FRAX site for Canada

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada